New Delhi, March 27: Union Minister of State for Health Anupriya Patel has said that India supplies nearly 30 percent of the world’s generic medicines and meets about 60 percent of global vaccine demand, underscoring the country’s role as the “Pharmacy of the World.” She highlighted that Indian pharmaceutical exports reach more than 200 countries, reflecting the sector’s strength in affordability, quality, and innovation.
Speaking at a health industry event, Patel noted that India’s pharmaceutical exports have grown significantly over the past decade, rising from $15.07 billion in 2013–14 to $27.85 billion in FY 2023–24. She emphasized that India’s low-cost manufacturing capabilities, strong research and development base, and compliance with international regulatory standards have made it a trusted supplier worldwide.
The minister added that India’s contribution during the COVID-19 pandemic, when it supplied essential medicines and vaccines to many nations, further reinforced its global reputation. “India continues to play a pivotal role in strengthening global healthcare supply chains and ensuring access to affordable medicines and vaccines,” she said.
Industry experts believe that India’s pharmaceutical sector will remain a key driver of economic growth, combining affordability with innovation and expanding its footprint in both developed and developing markets. The government has reiterated its commitment to supporting the industry through policy measures and international partnerships.
